$VRNS stock has now fallen 45% today, according to our price data from Polygon. There has been approximately $348,211,229 of trading volume.
It has been the 144th most-searched ticker on Quiver Quantitative over the last day, out of 9,808 total tickers searched.
Here is what we see in our data on $VRNS (you can track the company live on Quiver's $VRNS stock page):
$VRNS Insider Trading Activity
$VRNS insiders have traded $VRNS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $VRNS stock by insiders over the last 6 months:
- GUY MELAMED (CFO and COO) has made 0 purchases and 5 sales selling 110,386 shares for an estimated $6,264,165.
- DEN BOSCH FRED VAN has made 0 purchases and 2 sales selling 9,000 shares for an estimated $465,240.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRNS Hedge Fund Activity
We have seen 180 institutional investors add shares of $VRNS stock to their portfolio, and 148 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALYESKA INVESTMENT GROUP, L.P. added 2,195,730 shares (+inf%) to their portfolio in Q2 2025, for an estimated $111,433,297
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,550,178 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $78,671,533
- UBS GROUP AG removed 1,272,047 shares (-53.1%) from their portfolio in Q2 2025, for an estimated $64,556,385
- BANK OF MONTREAL /CAN/ removed 1,085,654 shares (-70.0%) from their portfolio in Q2 2025, for an estimated $55,096,940
- DEUTSCHE BANK AG\ removed 968,744 shares (-53.5%) from their portfolio in Q2 2025, for an estimated $49,163,758
- MILLENNIUM MANAGEMENT LLC added 917,662 shares (+86.2%) to their portfolio in Q2 2025, for an estimated $46,571,346
- SQUAREPOINT OPS LLC removed 797,569 shares (-96.1%) from their portfolio in Q2 2025, for an estimated $40,476,626
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VRNS Analyst Ratings
Wall Street analysts have issued reports on $VRNS in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 10/29/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/29/2025
- Susquehanna issued a "Positive" rating on 10/29/2025
- JP Morgan issued a "Overweight" rating on 10/27/2025
- Barclays issued a "Overweight" rating on 10/14/2025
- UBS issued a "Buy" rating on 09/29/2025
- Wedbush issued a "Outperform" rating on 09/03/2025
To track analyst ratings and price targets for $VRNS, check out Quiver Quantitative's $VRNS forecast page.
$VRNS Price Targets
Multiple analysts have issued price targets for $VRNS recently. We have seen 17 analysts offer price targets for $VRNS in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Shyam Patil from Susquehanna set a target price of $50.0 on 10/29/2025
- Rob Owens from Piper Sandler set a target price of $45.0 on 10/29/2025
- Jonathan Ruykhaver from Cantor Fitzgerald set a target price of $60.0 on 10/29/2025
- Mike Cikos from Needham set a target price of $55.0 on 10/29/2025
- Brian Essex from JP Morgan set a target price of $79.0 on 10/27/2025
- Shaul Eyal from TD Cowen set a target price of $68.0 on 10/17/2025
- Rudy Kessinger from DA Davidson set a target price of $55.0 on 10/14/2025
You can track data on $VRNS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
